Cc1ccc2c(c1)-c1c(c(C(=O)N3CCN(c4cc(Cl)ccc4C)CC3)nn1C)CS2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?